Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 reverse transcriptase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trypanosoma brucei | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Trypanosoma congolense | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Plasmodium yoelii | integrase-related | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | sodium:dicarboxylate symporter | 0.1916 | 1 | 1 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.1916 | 1 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.1916 | 1 | 1 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.1916 | 1 | 0.5 |
Loa Loa (eye worm) | excitatory amino acid transporter | 0.1916 | 1 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter excitatory amino acid transporter | 0.1916 | 1 | 1 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.1916 | 1 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.1916 | 1 | 1 |
Echinococcus granulosus | neutral amino acid transporter | 0.1916 | 1 | 0.5 |
Schistosoma mansoni | solute carrier family 1 (glial high affinity glutamate transporter | 0.1916 | 1 | 1 |
Mycobacterium tuberculosis | Probable C4-dicarboxylate-transport transmembrane protein DctA | 0.1916 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | Na+/H+-dicarboxylate symporter | 0.1916 | 1 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter A | 0.1916 | 1 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 3 | 0.1916 | 1 | 1 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.1916 | 1 | 1 |
Echinococcus granulosus | neutral amino acid transporter A | 0.1916 | 1 | 0.5 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.1916 | 1 | 1 |
Echinococcus granulosus | excitatory amino acid transporter 3 | 0.1916 | 1 | 0.5 |
Chlamydia trachomatis | glutamate symporter | 0.1916 | 1 | 1 |
Onchocerca volvulus | Excitatory amino acid transporter homolog | 0.1916 | 1 | 0.5 |
Echinococcus granulosus | sodium:dicarboxylate symporter | 0.1916 | 1 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.1916 | 1 | 1 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.1916 | 1 | 1 |
Treponema pallidum | glutamate/aspartate transporter | 0.0849 | 0 | 0.5 |
Treponema pallidum | glutamate transporter | 0.0849 | 0 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.1916 | 1 | 1 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.1916 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 60 uM | Concentration required to reduce by 50% the viability of noninfected treated CEM-CL13 cells | ChEMBL. | 9154976 |
CC50 (functional) | = 60 uM | Concentration required to reduce by 50% the viability of noninfected treated CEM-CL13 cells | ChEMBL. | 9154976 |
EC50 (functional) | = 0.26 uM | Inhibition of HIV-1 LA1 cytopathic effects on CEM-CL13 cells in vitro. | ChEMBL. | 9154976 |
EC50 (binding) | = 1.5 uM | Reverse transcriptase activity was measured in the culture supernatant, concentration that reduces by 50% the HIV produced in the supernatant. | ChEMBL. | 9154976 |
EC50 (binding) | = 1.5 uM | Reverse transcriptase activity was measured in the culture supernatant, concentration that reduces by 50% the HIV produced in the supernatant. | ChEMBL. | 9154976 |
Ratio (functional) | = 230 | Ratio of CC50 in CEM-CL13 cells to EC50 in HIV-1 LA1 infected CEM-CL13 cells. | ChEMBL. | 9154976 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.